Galza Met (50/1000mg) 14 Tablets
Vildagliptin 50mg and Metformin 1000mg for type 2 diabetes.
Galza Met 50/1000mg is a fixed-dose combination of vildagliptin 50mg (DPP-4 inhibitor) and metformin 1000mg. Vildagliptin enhances incretin-mediated glucose control; metformin reduces hepatic glucose production. Used for type 2 diabetes when diet and exercise are insufficient. One tablet twice daily.
Purpose
Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise.
Ingredients
Vildagliptin 50mg and Metformin hydrochloride 1000mg per tablet.
Warnings
Contraindicated in severe renal impairment, diabetic ketoacidosis. Risk of lactic acidosis; avoid in conditions predisposing to hypoxia. Not for type 1 diabetes.
Side Effects
Nausea, diarrhea, headache. Rare: lactic acidosis (metformin), pancreatitis (vildagliptin).
Storage Instructions
Store below 25°C in a dry place. Keep in original pack to protect from moisture.
| Brand | CCL |
| Status | Active |
Related Products
